logo
logo

Coya Therapeutics Secures $10 Million Financing To Advance Clinical And Pre-Clinical Pipeline Of Regulatory T Cell Therapeutics

Coya Therapeutics Secures $10 Million Financing To Advance Clinical And Pre-Clinical Pipeline Of Regulatory T Cell Therapeutics

06/07/22, 10:02 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svghouston
Money raised
$10 million
Coya Therapeutics, Inc. (Coya), a clinical-stage biotechnology company developing multiple first-in-class and best-in-class approaches that enhance regulatory T cell (Treg) function, today announced that it has raised approximately $10.3 million from institutional and accredited investors. The financing brings the total funding to date to over $20 million.

Company Info

Company
Coya
Location
houston, texas, united states
Additional Info
Coya is also developing first-in-class exosome therapies derived from ”Super Tregs” for autologous and allogeneic applications, as well as a novel biologic that works to upregulate Treg function in vivo.